8-K/AOther EventsExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K/A Report, Corporate Update (Aug 1, 2008)

Filed August 1, 2008For Securities:BMYCELG-RIBMYMP

Summary

This filing is an amendment (8-K/A) to a previous 8-K report filed by Bristol-Myers Squibb (BMY) on July 31, 2008. The amendment primarily serves to attach the transcript of an investor relations conference call held on July 31, 2008. This call discussed the company's proposal to acquire ImClone Systems Incorporated for $60 per share in cash. For investors, the key takeaway is the confirmation of BMY's strategic move to acquire ImClone, a significant development that was formally communicated and discussed with investors. The transaction price of $60 per share in cash sets a clear valuation benchmark for the proposed acquisition. Investors interested in the rationale and details of this deal should refer to the attached transcript for management's commentary and Q&A.

Key Highlights

  • 1Bristol-Myers Squibb (BMY) filed an amendment to its Form 8-K on August 1, 2008.
  • 2The amendment includes the transcript of an investor relations conference call held on July 31, 2008.
  • 3The conference call discussed BMY's proposal to acquire ImClone Systems Incorporated.
  • 4The proposed acquisition offer was $60 per share in cash.
  • 5The transcript provides further details and management commentary on the ImClone acquisition proposal.
  • 6This filing confirms and provides access to the discussion surrounding a significant strategic acquisition for BMY.

Frequently Asked Questions

This filing is an amendment to a previous Form 8-K. Its main purpose is to officially attach and incorporate the transcript of an investor relations conference call that took place on July 31, 2008, which discussed the proposed acquisition of ImClone Systems Incorporated.

The key event discussed was Bristol-Myers Squibb's (BMY) proposal to acquire ImClone Systems Incorporated. The company announced its intention to offer $60 per share in cash for ImClone.

Investors can find more details about the proposed acquisition in the transcript of the July 31, 2008 Investor Relations conference call, which is attached as Exhibit 99.2 to this Form 8-K/A filing and is incorporated by reference.

Bristol-Myers Squibb proposed to acquire ImClone Systems Incorporated for $60 per share in cash.